STOCKHOLM, Oct. 1, 2018 /PRNewswire/ -- Cantargia AB today announces that the United States Patent and Trademark Office (USPTO) has granted the company's patent application 15/501,710 directed to the antibody CAN03, which is of relevance for Cantargia's CANxx project. The patent number is...
from PR Newswire: //https://ift.tt/2OmS5Oy
No comments:
Post a Comment